Skip to main content
Equibles
KPTI logo

KPTI · Karyopharm Therapeutics Inc. · Exempt Offerings

Track KPTI — free

Use KPTI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KPTI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.48 0.00 (-0.44%) At close · Oct 27 Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding or other strategic alternatives and considering our debt service obligations and financial covenant to maintain minimum liquidity, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date the accompanying condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$10.93M
Shares
22.68M
Volume · Oct 27 996.52K Avg daily vol (3M) 1.95M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2022-12-08 New $165,000,003 $165,000,003
Showing 1–1 of 1 filings
Key facts CIK 1503802 CUSIP 48576U205 13F (30d) 10 filings 10 filers Visit website Investor relations